Vibegron for treating symptoms of overactive bladder syndrome (TA999)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 September 2024
Urinary incontinence in neurological disease: assessment and management (CG148)Product type:GuidanceProgramme:Clinical guidelineLast updated: 2 October 2023Published: 8 August 2012
Pelvic floor dysfunction: prevention and non-surgical management (NG210)Product type:GuidanceProgramme:NICE guidelinePublished: 9 December 2021
Axonics sacral neuromodulation system for treating refractory overactive bladder (HTG554)Product type:GuidanceProgramme:HealthTech guidancePublished: 3 September 2020
Urinary incontinence and pelvic organ prolapse in women: management (NG123)Product type:GuidanceProgramme:NICE guidelineLast updated: 24 June 2019Published: 2 April 2019
Mirabegron for treating symptoms of overactive bladder (TA290)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 June 2013
Bedwetting in under 19s (CG111)Product type:GuidanceProgramme:Clinical guidelinePublished: 27 October 2010